In the BioHarmony Drug Report Database

"Preview" Icon

Dinutuximab

Unituxin, Dinutuximab beta EUSA and Dinutuximab beta Apeiron, Qarziba (dinutuximab) is an antibody pharmaceutical. Dinutuximab was first approved as Unituxin on 2015-03-10. It is used to treat neuroblastoma in the USA. It has been approved in Europe to treat neuroblastoma.

 

Trade Name

 

Dinutuximab beta EUSA and Dinutuximab beta Apeiron, Qarziba
 

Common Name

 

dinutuximab
 

ChEMBL ID

 

CHEMBL3137342
 

Indication

 

neuroblastoma
 

Drug Class

 

Monoclonal antibodies: chimeric, tumors as target

Image (chem structure or protein)

Dinutuximab structure rendering